Guardant Health stockGH
Guardant Health trades at $153.43, 19.7% below its 52-week high (Oct 6, 2026). The price is below its 50-day but above its 200-day average: a pullback within an uptrend. +50.2% year to date, +61.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
- Market pulseGuardant Health Inc reports fiscal Q3 2026 results with non-GAAP EPS $-0.29 (+61% YoY) and revenue $361.0M (+36% YoY), beats EPS and revenue estimates
- BenzingaTwinStrand Biosciences Announces Confirmation Of U.S. Patent And Trademark Office Regarding Patentability Of All 23 Claims Of U.S. Patent Against Guardant Health
- BenzingaGuardant Health Q3 Adj. EPS $(0.29) Beats $(0.32) Estimate, Sales $360.975M Beat $350.358M Estimate
Ratings, candles, signals and the screener for GH — after you log in
Open the terminalFrequently asked questions about Guardant Health
What is the Guardant Health stock price?
At the close on Nov 5, 2026: $153.43 (−8.99% on the day). 52-week high: $191.05 on Oct 6, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Guardant Health report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −12% year over year, revenue +44%.
Does Guardant Health pay dividends?
No, Guardant Health does not pay dividends.
Where does Guardant Health trade and how to buy it?
Ticker GH, exchange Nasdaq, listed since 2018. You can buy it through a broker with access to US exchanges.
Should I buy Guardant Health now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for GH are in the terminal after you log in.